J&J Fends Off Xarelto Claims in First Bellwether Trial

, The National Law Journal

   | 0 Comments

Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. and Bayer brought in powerhouse litigator Beth Wilkinson of Washington, D.C.'s Wilkinson Walsh + Eskovitz to lead the defense team in the first of four bellwether trials.

This premium content is reserved for National Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202785210232

Thank you!

This article's comments will be reviewed.